DiscoverEmergency Medicine WorkforceHow the FTC's proposed ban on noncompete agreements could impact physicians, with Andrew Fisher
How the FTC's proposed ban on noncompete agreements could impact physicians, with Andrew Fisher

How the FTC's proposed ban on noncompete agreements could impact physicians, with Andrew Fisher

Update: 2023-03-15
Share

Description

On February 7th, 2023, the FTC announced its intent to prohibit non-compete agreements between an employer and employee. The ban has the potential to completely change the landscape of the physician workforce.

 
In this episode, we explore:

  • Non-competes, non-disclosures, and non-solicitations
  • What non-competes have historically meant for the EM workforce
  • What the FTC announcement means for physicians
  • Why a non-compete ban could have a $250-$300B impact
  • If a non-compete ban could raise physician salaries AND lower healthcare cost

About Our Guest:

Andrew Fisher is the founder and managing attorney at Fisher Corporate Law, a firm that’s focused on helping entrepreneurs, executives, and startups work through legal challenges.

Connect with us:
Instagram: https://www.instagram.com/emworkforce/
Twitter: https://twitter.com/emworkforce
LinkedIn: https://www.linkedin.com/company/emergency-medicine-workforce-productions/

Loved this episode? Leave us a review and rating here


Emergency Medicine Workforce is hosted by Dr. Leon Adelman, presented by Ivy Clinicians, and produced by Earfluence.



Sponsor
Ivy Clinicians, the Zillow of the Emergency Medicine Workforce
Sign up, and when you find the right job, we'll send you a bottle of champagne to celebrate!

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How the FTC's proposed ban on noncompete agreements could impact physicians, with Andrew Fisher

How the FTC's proposed ban on noncompete agreements could impact physicians, with Andrew Fisher

Leon Adelman, MD, MBA